Jersey Chen, MD, MPH

Subscribers migrated to Affordable Care Act—compliant plans with modestly higher costs, but had higher levels of insurance coverage and stronger consumer protections.

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.